Sabra Health Care Stock Cash And Equivalents
| SBC Stock | EUR 13.33 0.17 1.29% |
Sabra Health Care fundamentals help investors to digest information that contributes to Sabra Health's financial success or failures. It also enables traders to predict the movement of Sabra Stock. The fundamental analysis module provides a way to measure Sabra Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sabra Health stock.
Sabra |
Sabra Health Care Company Cash And Equivalents Analysis
Sabra Health's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Sabra Health Cash And Equivalents | 56.81 M |
Most of Sabra Health's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sabra Health Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Sabra Health Care has 56.81 M in Cash And Equivalents. This is 79.72% lower than that of the Real Estate sector and 52.88% lower than that of the REIT - Healthcare Facilities industry. The cash and equivalents for all Germany stocks is 97.9% higher than that of the company.
Sabra Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sabra Health's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sabra Health could also be used in its relative valuation, which is a method of valuing Sabra Health by comparing valuation metrics of similar companies.Sabra Health is currently under evaluation in cash and equivalents category among related companies.
Sabra Fundamentals
| Return On Equity | -0.0241 | |||
| Return On Asset | 0.0155 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 5.1 B | |||
| Shares Outstanding | 231.16 M | |||
| Shares Owned By Insiders | 1.35 % | |||
| Shares Owned By Institutions | 90.40 % | |||
| Price To Earning | 25.24 X | |||
| Price To Book | 0.90 X | |||
| Price To Sales | 6.70 X | |||
| Revenue | 624.81 M | |||
| Gross Profit | 372.8 M | |||
| EBITDA | 216.89 M | |||
| Net Income | (77.61 M) | |||
| Cash And Equivalents | 56.81 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 2.31 B | |||
| Debt To Equity | 106.60 % | |||
| Current Ratio | 5.91 X | |||
| Book Value Per Share | 13.23 X | |||
| Cash Flow From Operations | 315.73 M | |||
| Earnings Per Share | (0.33) X | |||
| Target Price | 19.14 | |||
| Number Of Employees | 42 | |||
| Beta | 1.29 | |||
| Market Capitalization | 2.59 B | |||
| Total Asset | 5.75 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.09 % | |||
| Net Asset | 5.75 B | |||
| Last Dividend Paid | 1.2 |
About Sabra Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sabra Health Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sabra Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sabra Health Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Health Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Sabra Stock analysis
When running Sabra Health's price analysis, check to measure Sabra Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Health is operating at the current time. Most of Sabra Health's value examination focuses on studying past and present price action to predict the probability of Sabra Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Health's price. Additionally, you may evaluate how the addition of Sabra Health to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |